22703631,22496199,22219231,22722632,22712157,21768599,22045326,22822237,22772876,22706836,20380819,22855866,22584158,22198405,22410446,22786590,21071506,21098406,22217609,22491871[uid] - Search Results

Year	Number of Results
2010	3
2011	4
2012	14
2014	1
2024	0

1

Parkinson disease and Alzheimer disease: environmental risk factors.

Campdelacreu J. Campdelacreu J. Neurologia. 2014 Nov-Dec;29(9):541-9. doi: 10.1016/j.nrl.2012.04.001. Epub 2012 Jun 14. Neurologia. 2014. PMID: 22703631 Free article. Review. English, Spanish.

2

A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease.

Richard IH, McDermott MP, Kurlan R, Lyness JM, Como PG, Pearson N, Factor SA, Juncos J, Serrano Ramos C, Brodsky M, Manning C, Marsh L, Shulman L, Fernandez HH, Black KJ, Panisset M, Christine CW, Jiang W, Singer C, Horn S, Pfeiffer R, Rottenberg D, Slevin J, Elmer L, Press D, Hyson HC, McDonald W; SAD-PD Study Group. Richard IH, et al. Neurology. 2012 Apr 17;78(16):1229-36. doi: 10.1212/WNL.0b013e3182516244. Epub 2012 Apr 11. Neurology. 2012. PMID: 22496199 Free PMC article. Clinical Trial.

3

Updates in the medical management of Parkinson disease.

Fernandez HH. Fernandez HH. Cleve Clin J Med. 2012 Jan;79(1):28-35. doi: 10.3949/ccjm.78gr.11005. Cleve Clin J Med. 2012. PMID: 22219231 Free article. Review.

4

Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes.

Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ Jr, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, Holloway K, Samii A, Horn S, Bronstein JM, Stoner G, Starr PA, Simpson R, Baltuch G, De Salles A, Huang GD, Reda DJ; CSP 468 Study Group. Weaver FM, et al. Neurology. 2012 Jul 3;79(1):55-65. doi: 10.1212/WNL.0b013e31825dcdc1. Epub 2012 Jun 20. Neurology. 2012. PMID: 22722632 Free PMC article. Clinical Trial.

5

Parkinson disease.

Park NH. Park NH. JAAPA. 2012 May;25(5):73-4. doi: 10.1097/01720610-201205000-00017. JAAPA. 2012. PMID: 22712157 Review. No abstract available.

6

Does vigorous exercise have a neuroprotective effect in Parkinson disease?

Ahlskog JE. Ahlskog JE. Neurology. 2011 Jul 19;77(3):288-94. doi: 10.1212/WNL.0b013e318225ab66. Neurology. 2011. PMID: 21768599 Free PMC article. Review.

7

Exercise and physical therapy in early management of Parkinson disease.

Alonso-Frech F, Sanahuja JJ, Rodriguez AM. Alonso-Frech F, et al. Neurologist. 2011 Nov;17(6 Suppl 1):S47-53. doi: 10.1097/NRL.0b013e31823968ec. Neurologist. 2011. PMID: 22045326 Review.

8

Exercise for people in early- or mid-stage Parkinson disease: a 16-month randomized controlled trial.

Schenkman M, Hall DA, Barón AE, Schwartz RS, Mettler P, Kohrt WM. Schenkman M, et al. Phys Ther. 2012 Nov;92(11):1395-410. doi: 10.2522/ptj.20110472. Epub 2012 Jul 19. Phys Ther. 2012. PMID: 22822237 Free PMC article. Clinical Trial.

9

Genetics of Parkinson disease and other movement disorders.

Kumar KR, Lohmann K, Klein C. Kumar KR, et al. Curr Opin Neurol. 2012 Aug;25(4):466-74. doi: 10.1097/WCO.0b013e3283547627. Curr Opin Neurol. 2012. PMID: 22772876 Review.

10

Treatment of Parkinson disease: a 64-year-old man with motor complications of advanced Parkinson disease.

Tarsy D. Tarsy D. JAMA. 2012 Jun 6;307(21):2305-14. doi: 10.1001/jama.2012.4829. JAMA. 2012. PMID: 22706836

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year